Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiopharma Cred. Share News (BPCR)

Share Price Information for Biopharma Cred. (BPCR)

Share Price is delayed by 15 minutes
Get Live Data
0.946    0.00 (0.00%)
Bid:
0.944
Ask:
0.946
Spread: 0.002 (0.212%)
Market Cap: $1.06b
BPCR Live PriceLast checked at - London Stock Exchange

Intraday Biopharma Cred. Share Chart

Biopharma Cred. News

BioPharma Credit Meets Dividend Target In 2019 As Net Assets Rise
10 Mar 2020

BioPharma Credit Meets Dividend Target In 2019 As Net Assets Rise

BioPharma Credit Meets Dividend Target In 2019 As Net Assets Rise

BioPharma Credit Declares Interim Dividend Of USD0.0303 Per Share
20 Feb 2020

BioPharma Credit Declares Interim Dividend Of USD0.0303 Per Share

BioPharma Credit Declares Interim Dividend Of USD0.0303 Per Share

BioPharma Credit To Provide USD200 Million Loan To Collegium Pharma
7 Feb 2020

BioPharma Credit To Provide USD200 Million Loan To Collegium Pharma

BioPharma Credit To Provide USD200 Million Loan To Collegium Pharma

BioPharma Credit puts $165m into pharma firm Collegium via loan
7 Feb 2020

BioPharma Credit puts $165m into pharma firm Collegium via loan

(Sharecast News) - Specialist life sciences investor BioPharma Credit has entered into a definitive senior secured term loan agreement with Collegium ...

BioPharma Credit Invests USD82.5 Million In Global Blood Therapeutics
18 Dec 2019

BioPharma Credit Invests USD82.5 Million In Global Blood Therapeutics

BioPharma Credit Invests USD82.5 Million In Global Blood Therapeutics

Biopharma Credit Loans Sarepta Therapeutics USD450 Million
13 Dec 2019

Biopharma Credit Loans Sarepta Therapeutics USD450 Million

Biopharma Credit Loans Sarepta Therapeutics USD450 Million

BioPharma Credit Invests In Biopharmaceutical Firms Epizyme And Akebia
13 Nov 2019

BioPharma Credit Invests In Biopharmaceutical Firms Epizyme And Akebia

BioPharma Credit Invests In Biopharmaceutical Firms Epizyme And Akebia

BioPharma Credit pours cash into US firms Epizyme and Akebia
13 Nov 2019

BioPharma Credit pours cash into US firms Epizyme and Akebia

(Sharecast News) - Specialist life sciences debt investor BioPharma Credit has entered into two separate loan agreements, where it will invest $52.5m ...